
CheckMark
CheckMark provides an MSP-funded teledermoscopy service that lets patients in British Columbia receive a dermatologist-reviewed assessment of concerning skin spots within 48–72 hours. The service operates through participating community pharmacies, where trained staff capture standardized dermoscopic images after a family doctor or nurse practitioner submits a referral. CheckMark coordinates follow-up care, including reassurance, biopsy, or further treatment, based on the dermatologist's clinical report.
- Healthcare Technology
- Digital Health
- Software Only
Funding
Founders
Founder details are not available yet.
Product
Problem
In British Columbia, the average wait for a dermatology appointment is 6 to 12 months, during which early-stage skin lesions can progress into serious conditions. Patients and referring providers lack a timely, accessible pathway for specialist assessment of concerning skin spots, creating prolonged anxiety and delayed treatment for skin cancer, one of the most common and treatable cancers when caught early.
Solution
CheckMark is an MSP-funded teledermoscopy service that brings specialist skin cancer triage into community pharmacies. A family doctor or nurse practitioner identifies 1 to 2 concerning lesions and sends a referral to CheckMark, after which the patient books an appointment at a participating pharmacy. A trained staff member captures standardized dermoscopic images during a roughly 10-minute visit, and a licensed BC dermatologist reviews the images and prepares a full clinical report within 48 to 72 hours. The patient and their provider receive the report, and CheckMark coordinates any next steps, including reassurance, biopsy, or further care as needed. The entire pathway, from referral to results, is designed to be completed in under two weeks.
Target Audience
Primary users are patients in British Columbia with concerning skin spots or moles who have received a referral from a family doctor or nurse practitioner, as well as the referring providers and participating community pharmacies that facilitate the assessment pathway.
Features
- Referral-based pathway requiring only 1 to 2 concerning lesions per patient, streamlining the triage process
- Standardized dermoscopic image capture performed by trained pharmacy staff, ensuring consistent image quality for remote review
- Licensed BC dermatologist review with a full clinical report delivered within 48 to 72 hours
- MSP coverage for eligible BC patients, eliminating out-of-pocket costs for the assessment
- Participating pharmacy network across British Columbia, including locations in Port Moody, Burnaby, Victoria, and Kamloops, with expansion underway
- Coordinated follow-up care management, including reassurance, biopsy scheduling, or referral for further treatment